A potential role for SELENOF in carcinogenesis in multiple organ types is indicated by several lines of evidence, including loss of heterozygosity in breast cancers [11,12] and the association of specific polymorphisms of SELENOF and the risk of colorectal cancer [13,14]. The gene discussed is SELENOF; the disease is colorectal cancer.